Connor, Clark & Lunn Investment Management Ltd. Medpace Holdings, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 86,566 shares of MEDP stock, worth $26.5 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
86,566
Previous 65,416
32.33%
Holding current value
$26.5 Million
Previous $21.7 Million
21.36%
% of portfolio
0.13%
Previous 0.11%
Shares
23 transactions
Others Institutions Holding MEDP
# of Institutions
624Shares Held
26.1MCall Options Held
46.4KPut Options Held
80.8K-
Black Rock Inc. New York, NY2.58MShares$791 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$777 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.19MShares$364 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT829KShares$254 Million1.43% of portfolio
-
State Street Corp Boston, MA783KShares$240 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $9.54B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...